Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy

Authors

Toshibumi Taniguchi, Washington University School of Medicine in St. Louis
Diana Nurutdinova, St. Louis VA Medical Center
Jessica R. Grubb, Washington University School of Medicine in St. Louis
Nur F. Önen, Washington University School of Medicine in St. Louis
Enbal Sacham, Washington University in St Louis
Michael Donovan, Washington University School of Medicine in St. Louis
Edgar Turner Overton, Washington University School of Medicine in St. Louis

Journal

AIDS Research and Human Retroviruses

Publication Date

3-5-2012

Volume

28

Issue

3

Inclusive Pages

259-264

Document Type

Open Access Publication

DOI

10.1089/aid.2011.0022

Rights and Permissions

Toshibumi Taniguchi, Diana Nurutdinova, Jessica R. Grubb, Nur F. Önen, Enbal Shacham, Michael Donovan, and Edgar Turner Overton. AIDS Research and Human Retroviruses. March 2012, 28(3): 259-264. doi:10.1089/aid.2011.0022

Recommended Citation

Taniguchi, Toshibumi; Nurutdinova, Diana; Grubb, Jessica R.; Önen, Nur F.; Sacham, Enbal; Donovan, Michael; and Turner Overton, Edgar, "Transmitted drug-resistant HIV type 1 remains prevalent and impacts virologic outcomes despite genotype-guided antiretroviral therapy." AIDS Research and Human Retroviruses. 28, 3. 259-264. (2012).
https://digitalcommons.wustl.edu/open_access_pubs/2793